Happiness Biotech Group, a China-based nutraceutical and herbal dietary supplements producer, announced terms for its IPO on Friday.
The Nanping, China-based company plans to raise $13 million by offering 2.4 million shares (17% insider) at a price range of $5 to $6. At the midpoint of the proposed range, Happiness Biotech Group would command a market value of $138 million.
Happiness Biotech Group was founded in 2004 and it plans to list on the Nasdaq under the symbol HAPP. Univest Securities is the sole bookrunner on the deal.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.